نتائج البحث - "Second Primary"

المساهمون: Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Pneumologie - Oncologie Thoracique - Maladies Pulmonaires Rares [CHU Tenon], CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service d'Hématologie clinique [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Hôpital de la Timone [CHU - APHM] (TIMONE), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Rhumatologie [Sainte- Marguerite - APHM] ( Hôpitaux Sud), Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )

المصدر: Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2021, 155, ⟨10.1016/j.bulcan.2021.01.026⟩

مصطلحات موضوعية: Oncology, Male, Cancer Research, Lung Neoplasms, Human immunodeficiency virus (HIV), medicine.disease_cause, 0302 clinical medicine, Second cancer, 030212 general & internal medicine, education.field_of_study, Incidence (epidemiology), Incidence, Lymphoma, Non-Hodgkin, Liver Neoplasms, Neoplasms, Second Primary, Non-AIDS-defining cancers, Hematology, General Medicine, Anal canal, Middle Aged, Anus Neoplasms, Hodgkin Disease, 3. Good health, medicine.anatomical_structure, Cancers non-classant-SIDA, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Female, Sarcoma, France, Colorectal Neoplasms, Viral load, Adult, medicine.medical_specialty, Population, HIV Long-Term Survivors, 03 medical and health sciences, Life Expectancy, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, education, Sarcoma, Kaposi, business.industry, Cancer, HIV, VIH, medicine.disease, Bile Duct Neoplasms, Urinary Bladder Neoplasms, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d661abaa4ef8a1f5126faccbd7a7e093Test
https://hal.sorbonne-universite.fr/hal-03356180Test

5

Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study

المؤلفون: Renata Abrahão, Theresa H.M. Keegan, Elysia Alvarez, Raul C. Ribeiro, Theodore Wun, Marcio H. Malogolowkin, Qian W. Li

المصدر: Br J Haematol
British journal of haematology, vol 190, iss 3

مصطلحات موضوعية: Lymphoma, Respiratory Tract Diseases, Avascular necrosis, Cardiorespiratory Medicine and Haematology, 0302 clinical medicine, Cancer Survivors, Neoplasms, Cumulative incidence, Registries, Young adult, Aetiology, AIDS-Related, Cancer, Lymphoma, AIDS-Related, Pediatric, Incidence (epidemiology), non-Hodgkin lymphoma, Incidence, Lymphoma, Non-Hodgkin, Neoplasms, Second Primary, Hematology, Second Primary, population-based study, Cardiovascular Diseases, 030220 oncology & carcinogenesis, HIV/AIDS, Female, Kidney Diseases, Adult, medicine.medical_specialty, Adolescent, Digestive System Diseases, Immunology, Non-Hodgkin, Endocrine System Diseases, Article, 03 medical and health sciences, Young Adult, Rare Diseases, Clinical Research, Survivorship curve, Internal medicine, medicine, Endocrine system, late effects, Humans, Proportional Hazards Models, business.industry, adolescent and young adult, medicine.disease, Cancer registry, Good Health and Well Being, Socioeconomic Factors, Chronic Disease, Nervous System Diseases, business, Digestive Diseases, 030215 immunology, 2.4 Surveillance and distribution

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce30751668bab4b16c2e38cdebb8daddTest
https://europepmc.org/articles/PMC9245545Test/

6

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

المؤلفون: Elena Maria Elli, Florian H. Heidel, Uros Markovic, Fabrizio Pane, Gianpietro Semenzato, Daniela Bartoletti, Francesca Palandri, Giulia Benevolo, Mauro Krampera, Malgorzata Monika Trawinska, Micaela Bergamaschi, Mario Tiribelli, Giovanni Caocci, Lucia Catani, Elisabetta Abruzzese, Massimo Breccia, Rossella Stella, Antonio Cuneo, Fabio D'Amore, Alessandro Isidori, Costanza Bosi, Monica Crugnola, Lisa Gandolfi, Domenico Russo, Alessandra Iurlo, Nicola Polverelli, Roberto M. Lemoli, Michele Cavo, Gianni Binotto, Roberto Latagliata, Francesco Cavazzini, Bruno Martino, Daniele Cattaneo, Nicola Vianelli, Novella Pugliese, Luigi Scaffidi, Massimiliano Bonifacio, Mariella D'Adda, Alessia Tieghi, Giuseppe Auteri, Giuseppe A. Palumbo

المساهمون: Polverelli N., Elli E.M., Abruzzese E., Palumbo G.A., Benevolo G., Tiribelli M., Bonifacio M., Tieghi A., Caocci G., D'Adda M., Bergamaschi M., Binotto G., Heidel F.H., Cavazzini F., Crugnola M., Pugliese N., Bosi C., Isidori A., Bartoletti D., Auteri G., Latagliata R., Gandolfi L., Martino B., Scaffidi L., Cattaneo D., D'Amore F., Trawinska M.M., Stella R., Markovic U., Catani L., Pane F., Cuneo A., Krampera M., Semenzato G., Lemoli R.M., Vianelli N., Breccia M., Russo D., Cavo M., Iurlo A., Palandri F.

مصطلحات موضوعية: Male, Ruxolitinib, Skin Neoplasms, Lymphoma, ruxolitinib, Aggressive lymphoma, Gastroenterology, Hydroxycarbamide, 0302 clinical medicine, myelofibrosi, Risk Factors, Neoplasms, 80 and over, Aged, 80 and over, Thrombocytosis, Incidence (epidemiology), Incidence, Hazard ratio, Neoplasms, Second Primary, Hematology, Arteries, Middle Aged, Second Primary, JAK inhibitor, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, medicine.medical_specialty, Context (language use), myelofibrosis, JAK inhibitors, second cancer, toxicity, NO, 03 medical and health sciences, Internal medicine, Nitriles, medicine, Humans, Janus Kinase Inhibitors, Myelofibrosis, Aged, Retrospective Studies, business.industry, Thrombosis, medicine.disease, Case-Control Studies, Follow-Up Studies, Multivariate Analysis, Primary Myelofibrosis, Pyrazoles, Pyrimidines, business, 030215 immunology

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8abbcaca804c8d9620fa8227a1112fTest
http://hdl.handle.net/11562/1033116Test

7

Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents

المساهمون: University of Rome TorVergata, European Society for Blood and Marrow Transplantation (EBMT), Service d’Hématologie [Institut Paoli Calmettes, Marseille], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Department of Clinical Haematology, Nottingham University Hospitals—City Campus, Dept. of Hematology, University hospitals, Department of Haematology, Charles University Hospital, University Hospital Brno, Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw - Poland, Department of Hematology, University Hospital Lund, Trinity College Dublin, Department I of Internal Medicine, University of Cologne, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Lille Inflammation Research International Center - U 995 (LIRIC), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Queen's University [Belfast] (QUB), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University Hospital Hamburg-Eppendorf, Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), National Institute for Health Research

المصدر: Biology of Blood and Marrow Transplantation, 24, 930-936
Biology of Blood and Marrow Transplantation, 24, 5, pp. 930-936
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (5), pp.930-936. ⟨10.1016/j.bbmt.2018.01.006⟩

مصطلحات موضوعية: Male, Oncology, Benzylamines, [SDV]Life Sciences [q-bio], Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], medicine.medical_treatment, Hematopoietic stem cell transplantation, Cyclams, 0302 clinical medicine, Heterocyclic Compounds, Cumulative incidence, Prospective Studies, Prospective cohort study, Multiple myeloma, Incidence, Incidence (epidemiology), Age Factors, Hematopoietic Stem Cell Transplantation, Neoplasms, Second Primary, Hematology, Middle Aged, second primary malignancies, Hematopoietic Stem Cell Mobilization, 3. Good health, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, medicine.drug, Adult, medicine.medical_specialty, Immunology, proteasome inhibitors, Transplantation, Autologous, Settore MED/01 - Statistica Medica, Young Adult, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, immunomodulatory drugs, Internal medicine, medicine, Humans, Autologous transplantation, Aged, Transplantation, business.industry, Plerixafor, fungi, plerixafor, 1103 Clinical Sciences, medicine.disease, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::575a809929193312552012e1b04e3251Test
https://doi.org/10.1016/j.bbmt.2018.01.006Test

8

Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era

المصدر: British Journal of Haematology. 187:364-371

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Adolescent, Follicular lymphoma, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, In patient, Registries, Lymphoma, Follicular, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Incidence (epidemiology), Late effect, Neoplasms, Second Primary, Retrospective cohort study, Hematology, Middle Aged, medicine.disease, Confidence interval, Survival Rate, Standardized mortality ratio, Hematologic Neoplasms, 030220 oncology & carcinogenesis, Female, Rituximab, medicine.symptom, business, Follow-Up Studies, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fab2ab1e0caa59dee30edc5be26d40eTest
https://doi.org/10.1111/bjh.16090Test

9

Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study

المؤلفون: Carlos Besses, Gunnar Birgegård, Martin Griesshammer, Heinrich Achenbach, Jean-Jacques Kiladjian, Hans Garmo, Jingyang Wu, Folke Folkvaljon, Luigi Gugliotta, Claire N. Harrison, Lars Holmberg

المصدر: Gunnar, B, Folke, F, Hans, G, Lars, H, Carlos, B, Martin, G, Luigi, G, Jinyang, W, Heinrich, A, Jean-Jacques, K & Claire, N H 2018, ' Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study ', Leukemia Research . https://doi.org/10.1016/j.leukres.2018.10.006Test

مصطلحات موضوعية: Adult, Male, Oncology, malignant transformation, Cancer Research, medicine.medical_specialty, acute myelogenous leukemia, Acute myelogenous leukemia, Hydroxycarbamide, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Hydroxyurea, Prospective cohort study, Aged, Aged, 80 and over, Acute leukemia, business.industry, Essential thrombocythemia, Incidence (epidemiology), hydroxycarbamide, Neoplasms, Second Primary, Anagrelide, Hematology, Middle Aged, medicine.disease, Leukemia, Myeloid, Acute, Leukemia, Cell Transformation, Neoplastic, Malignant transformation, 030220 oncology & carcinogenesis, Quinazolines, anagrelide, Female, Skin cancer, business, Thrombocythemia, Essential, 030215 immunology, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88181524487c885e10c69996f7fc409Test
https://doi.org/10.1016/j.leukres.2018.10.006Test

10

Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data

المؤلفون: Armin Ghobadi, Francesca Ferraro, Peter Westervelt, Keith Stockerl-Goldstein, John F. DiPersio, Feng Gao

المصدر: Leuk Res

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Transplantation Conditioning, Multivariate analysis, Adolescent, Lymphoblastic Leukemia, Article, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Retrospective analysis, Humans, Risk factor, Child, Adverse effect, Aged, Aged, 80 and over, business.industry, Incidence, Incidence (epidemiology), Neoplasms, Second Primary, Hematology, Transplant-Related Mortality, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Allografts, Oncology, Child, Preschool, 030220 oncology & carcinogenesis, Meta-analysis, Female, business, Stem Cell Transplantation, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dabd7f73edd337cc2d676b3f3a9e0e1Test
https://doi.org/10.1016/j.leukres.2018.07.024Test

تنقيح النتائج